Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.70 |
| ▸ | LMNA | P02545 | 2/20 | 0.66 |
| ▸ | F2 | P00734 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | ESR1 | P03372 | 1/20 | 0.51 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.48 |
| ▸ | GSK3B | P49841 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methoxymethane SCHEMBL27549312 | 0.94 | LMNA (0.65) | TDP1LMNAF2MAPK1HIF1A | |
| SCHEMBL11233009 | 0.89 | TDP1 (0.54) | TDP1LMNAMAPK1SLC6A2KMT2A | |
| SCHEMBL20302724 | 0.89 | TDP1 (0.61) | TDP1LMNAF2MAPK1HIF1A | |
| SCHEMBL3180251 | 0.88 | TDP1 (0.78) | TDP1LMNAF2MAPK1HIF1A | |
| SCHEMBL137486 | 0.87 | TDP1 (0.83) | TDP1LMNAF2MAPK1HIF1A | |
| SCHEMBL3793158 | 0.86 | TDP1 (0.81) | TDP1LMNAF2MAPK1HIF1A | |
| SCHEMBL11741530 | 0.85 | TDP1 (0.79) | TDP1LMNAMAPK1HIF1ASLC6A2 | |
| SCHEMBL14673012 | 0.85 | TDP1 (0.79) | TDP1LMNAMAPK1HIF1ASLC6A2 | |
| SCHEMBL14673257 | 0.85 | TDP1 (0.79) | TDP1LMNAMAPK1HIF1ASLC6A2 | |
| SCHEMBL14673582 | 0.85 | TDP1 (0.79) | TDP1LMNAMAPK1HIF1ASLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109694423-B | Catalyst component for ethylene polymerization, preparation method thereof and catalyst for ethylene polymerization | 中国石油化工股份有限公司 | 2021-07-30 | — | — | CN | claimed |
| EP-4705289-A1 | PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF | Terran Biosciences Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4638658-A1 | PYROLYSIS OIL PURIFICATION USING SUCCESSIVE EXTRACTIONS | SABIC Global Technologies B.V. (NL) | 2025-10-29 | — | — | EP | disclosed |
| CN-119677713-A | Processes for preparing benzoates and intermediates thereof | 罗卡福拉达有限公司 | 2025-03-21 | — | — | CN | disclosed |
| WO-2024226691-A1 | PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF | TERRAN BIOSCIENCES INC. (US) | 2024-10-31 | — | — | WO | disclosed |
| WO-2024134356-A1 | PYROLYSIS OIL PURIFICATION USING SUCCESSIVE EXTRACTIONS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2024-06-27 | — | — | WO | disclosed |
| CN-116284778-A | Polybenzimidazole with cross-linked structure, high-temperature proton exchange membrane and preparation method thereof | 上海空间电源研究所 | 2023-06-23 | — | — | CN | disclosed |
| CN-114773215-B | Oil field oily sewage oil removing agent and preparation method and application thereof | 山东科兴化工有限责任公司 | 2022-09-02 | — | — | CN | disclosed |
| US-11420963-B2 | Rebamipide prodrugs, preparation method and use thereof | SAMJIN PHARMACEUTICAL CO., LTD. (KR) | 2022-08-23 | — | — | US | disclosed |
| CN-114773215-A | Oil field oily sewage oil removing agent and preparation method and application thereof | 山东科兴化工有限责任公司 | 2022-07-22 | — | — | CN | disclosed |
| US-5789455-A | Fluorine-containing hydrocarbon composition | ASAHI GLASS COMPANY LTD. (JP) | 1998-08-04 | — | — | US | disclosed |
| CN-1159183-A | Di- (2-haloethyl) aminophenyl substituted distamycin derivatives as anticancer and antiviral agents | PHARMACIA & UPJOHN SPA (IT) | 1997-09-10 | — | — | CN | disclosed |
| US-5616705-A | N-substituted azabicycloheptane derivatives, their preparation and use | BASF AKTIENGESELLSCHAFT (DE) | 1997-04-01 | — | — | US | disclosed |
| EP-0234045-B1 | A PYRAZOLE OXIME DERIVATIVE AND ITS PRODUCTION AND USE | NIHON NOHYAKU CO., LTD. (JP) | 1992-09-02 | — | — | EP | disclosed |
| US-5021330-A | Light sensitive silver halide emulsion layer | AGFA GEVAERT AKTIENGESELLSCHAFT (DE) | 1991-06-04 | — | — | US | disclosed |
| US-4843068-A | INSECTICIDES, MITICIDES, FUNGICIDES | NIHON NOHYAKU CO., LTD. (JP) | 1989-06-27 | — | — | US | disclosed |
| EP-0234045-A2 | A pyrazole oxime derivative and its production and use | NIHON NOHYAKU CO., LTD. (JP) | 1987-09-02 | — | — | EP | disclosed |
| US-4612386-A | Process for making esters | THE DOW CHEMICAL COMPANY (US) | 1986-09-16 | — | — | US | disclosed |
| US-4568759-A | Preparation of epoxides | THE DOW CHEMICAL COMPANY (US) | 1986-02-04 | — | — | US | disclosed |
| US-4356295-A | COORDINATION CATALYSTS | MITSUBISHI PETROCHEMICAL COMPANY LIMITED (JP) | 1982-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11420963-B2 | Rebamipide prodrugs, preparation method and use thereof | SI, CYP2A7, MLN | TDP1 649/4885LMNA 4782/4885F2 2267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.